A detailed history of Halpern Financial, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Halpern Financial, Inc. holds 200 shares of PFE stock, worth $5,344. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$5,344
Previous $5.6 Million 2.25%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Sep 21, 2023

SELL
$41.75 - $54.5 $7,890 - $10,300
-189 Reduced 48.59%
200 $10.2 Million
Q3 2022

Sep 21, 2023

SELL
$43.76 - $53.42 $8,226 - $10,042
-188 Reduced 32.58%
389 $17 Million
Q2 2022

Sep 21, 2023

BUY
$46.53 - $55.17 $8,747 - $10,371
188 Added 48.33%
577 $30.3 Million
Q4 2019

Sep 21, 2023

BUY
$32.92 - $37.36 $12,805 - $14,533
389 New
389 $15.2 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Halpern Financial, Inc. Portfolio

Follow Halpern Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Halpern Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Halpern Financial, Inc. with notifications on news.